✦ LIBER ✦

Concordance in pathological response to neoadjuvant chemotherapy between invasive and noninvasive components of primary breast carcinomas

✍ Scribed by Kaneyuki Matsuo; Takashi Fukutomi; Toru Watanabe; Tadashi Hasegawa; Hitoshi Tsuda; Sadako Akashi-Tanaka

Publisher: Springer Japan
Year: 2002
Tongue: English
Weight: 938 KB
Volume: 9
Category: Article
ISSN: 1340-6868
DOI: 10.1007/bf02967551

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Molecular classification system identifi

Molecular classification system identifies invasive breast carcinoma patients who are most likely and those who are least likely to achieve a complete pathologic response after neoadjuvant chemotherapy

✍ Neal S. Goldstein; David Decker; Dawn Severson; Scott Schell; Frank Vicini; Jeff 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 1 views

## Abstract ## BACKGROUND. The molecular classification system categorizes invasive breast carcinomas according to their key driving biomarkers. In the current study, the authors evaluated whether response to neoadjuvant chemotherapy was correlated with the molecular classification groups. ## MET

Correlation between HER-2 expression and

Correlation between HER-2 expression and response to neoadjuvant chemotherapy with 5-fluorouracil, doxorubicin, and cyclophosphamide in patients with breast carcinoma

✍ Fan Zhang; Ying Yang; Terry Smith; Shu-Wan Kau; Judy M. McConathy; Francisco J. 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB 👁 2 views

## Abstract ## BACKGROUND The objective of this study was to determine whether HER‐2 overexpression is associated with improved response to neoadjuvant chemotherapy with 5‐fluorouracil, doxorubicin, cyclophosphamide (FAC) in patients with breast carcinoma. ## METHODS Ninety‐seven patients with S

The activity of phosphohexose isomerase

The activity of phosphohexose isomerase in primary breast carcinomas and response to chemotherapy in patients with metastatic disease

✍ Irene Mitchell; N. Deshpande; Rosemary Millis; R. D. Rubens 📂 Article 📅 1986 🏛 Springer 🌐 English ⚖ 269 KB

Phase 2 trial of primary systemic therap

Phase 2 trial of primary systemic therapy with doxorubicin and docetaxel followed by surgery, radiotherapy, and adjuvant chemotherapy with cyclophosphamide, methotrexate, and 5-fluorouracil based on clinical and pathologic response in patients with stage IIB to III breast cancer : Long-term results from The University of Texas M. D. Anderson Cancer Center Study ID97-099

✍ Ricardo H. Alvarez; Daniel J. Booser; Massimo Cristofanilli; Aysegul A. Sahin; E 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 199 KB 👁 2 views